Neuroleptic malignant syndrome in trauma patient

Burns

Volumn 41, Issue 6, 2015, Pages 1147-1151

  Gragnani, Alfredo ^a   Cezillo, Marcus Vinicius Boaretto ^a   Oliveira, Andrea Fernandes ^a   Ferreira, Lydia Masako ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Burn; Burn care; Injury; Neuroleptic; Syndrome; Trauma

Indexed keywords

NEUROLEPTIC AGENT;

ACUTE PHASE RESPONSE; ARTICLE; BURN PATIENT; EARLY DIAGNOSIS; HUMAN; HYPERTHERMIA; INJURY; MULTIPLE TRAUMA; NEUROLEPTIC MALIGNANT SYNDROME; NONHUMAN; PROGNOSIS; BURN; COMPLICATION; RISK FACTOR;

ANTIPSYCHOTIC AGENTS; BURNS; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; RISK FACTORS; WOUNDS AND INJURIES;

EID: 84940447417     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2015.01.015     Document Type: Review

References (42)

1. R.D. Adams, M. Victor, and A.H. Ropper Principles of neurology Psychiatr Serv 49 9 1998 1163 1172 (6th ed., p1199)
2. K. Star, N. Iessa, N.B. Almandil, L. Wilton, S. Curran, I.R. Edwards, and et al. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis J Child Adolesc Psychopharmacol 22 6 2012 440 451
3. N. Cawrse, S. Wilson, M. Williams, and T. Burge Neuroleptic malignant syndrome in the burns patient? Burns 32 2006 647 649
4. S. Stübner, E. Rustenbeck, R. Grohmann, G. Wagner, R. Engel, G. Neundörfer, and et al. Severe and uncommon involuntary movement disorders due to psychotropic drugs Pharmacopsychiatry 37 Suppl. 1 2004 S54 S64
5. R. Nachreiner, J. Balledux, M. Zieger, O. Viegas, and R. Sood Neuroleptic malignant syndrome associated with metoclopramide in a burn patient J Burn Care Res 27 2 2006 237 241
6. J.R. Strawn, P.E. Keck Jr., and S.N. Caroff Neuroleptic malignant syndrome Am J Psychiatry 164 June (6) 2007 870 876
7. B. Margetić, and B. Aukst-Margetić Neuroleptic malignant syndrome and its controversies Pharmacoepidemiol Drug Saf 19 May (5) 2010 429 435
8. A.S. Robb, W. Chang, H.K. Lee, and M.S. Cook Risperidone-induced neuroleptic malignant syndrome in an adolescent J Child Adolesc Psychopharmacol 10 2000 327 330
9. R.E. Anglin, P.I. Rosebush, and F.M. Mazurek Neuroleptic malignant syndrome: a neuroimmunologic hypothesis CMAJ 182 18 2010 E834 E838
10. S. Lee Serum iron in catatonia and neuroleptic malignant syndrome Biol Psychiatry 44 1998 499 507
11. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454
12. D. Burger, and J. Dayer Cytokines, acute-phase proteins, and hormones Ann N Y Acad Sci 966 2002 464 473
13. A. Bouchama, and J.P. Knochel Heat stroke N Engl J Med 346 2002 1978 1988
14. P.I. Rosebush, and M.F. Mazurek Serum iron and neuroleptic malignant syndrome Lancet 338 8760 1991 149 151
15. J. Still, B. Friedman, E. Law, S. Deppe, N. Epperly, and H. Orlet Neuroleptic malignant syndrome in a burn patient Burns 24 September (6) 1998 573 575
16. M. Khan, and D. Farver Recognition, assessment and management of neuroleptic malignant syndrome S D J Med 53 2000 395 400
17. J.L. Levenson Neuroleptic malignant syndrome Am J Psychiatry 142 1985 1137 1145
18. A. Lazarus, S.C. Mann, and S.N. Caroff The neuroleptic malignant syndrome and related conditions 1989 American Psychiatric Press Inc. Washington, DC
19. American Psychiatric Association Diagnostic and statistical manual for mental disorders 4th ed. 1994 American Psychiatric Association Washington, DC
20. L. Prager, F. Millham, and T.A. Stern Neuroleptic malignant syndrome: a review for intensivists J Intensive Care Med 9 1994 227 234
21. C.J. Lavie, T.R. Olmsted, H.O. Ventura, and B.J. Lepler Neuroleptic malignant syndrome: an undiagnosed reaction to neuroleptic agents? Postgrad Med 80 3 1986 171 178
22. A. Shalev, and H. Munitz The neuroleptic malignant syndrome: agent and host interaction Acta Paediatr Scand 73 4 1986 337 347
23. V.R. Velamoor, R.M.G. Norman, and S.N. Caroff Progression of symptoms in neuroleptic malignant syndrome J Nerv Ment Dis 182 1994 168 173
24. S. Gupta, and N.D. Nihalani Neuroleptic malignant syndrome: a primary care perspective Prim Care Companion J Clin Psychiatry 6 5 2004 191 194
25. A.K. Parry, L.P. Ormerod, G.W. Hamlin, and P.T. Saleem Recurrent sinus arrest in association with neuroleptic malignant syndrome Br J Psychiatry 164 5 1994 689
26. B.H. Guzé, and L.R. Baxter Jr. Current concepts. Neuroleptic malignant syndrome N Engl J Med 313 3 1985 163
27. L. Gregorakos, T. Thomaides, S. Stratouli, and E. Sakayanni The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome Clin Auton Res 10 4 2000 193
28. M.G. Blue, S.M. Schneider, S. Noro, and D.S. Fraley Successful treatment of neuroleptic malignant syndrome with sodium nitroprusside Ann Intern Med 104 1 1986 56
29. Prevention and treatment of heat injury Med Lett Drugs Ther 45 1161 2003 58 60
30. H. Tanii, N. Taniguchi, H. Niigawa, T. Hosono, Y. Ikura, S. Sakamoto, and et al. Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level Brain Res 743 1-2 1996 263
31. M.R. Rosenberg, and M. Green Neuroleptic malignant syndrome. Review of response to therapy Arch Intern Med 149 9 1989 1927
32. V.M. Kothari, and D.R. Karnad New onset fever in the intensive care unit J Assoc Physicians India 53 2005 949 953
33. C. Burke, G.J. Fulda, and J. Castellano Neuroleptic malignant syndrome in a trauma patient J Trauma 39 4 1995 796 798
34. S.N. Caroff Neuroleptic malignant syndrome S.C. Mann, S.N. Caroff, P.E. Keck Jr. A. Lazarus, Neuroleptic malignant syndrome and related conditions 2nd ed. 2003 American Psychiatric Publishing Inc. Washington, DC 1 44
35. D.A. White, and A.H. Robins Catatonia: harbinger of the neuroleptic malignant syndrome Br J Psychiatry 158 1991 419 421
36. A.M. Haddow, D. Harris, M. Wilson, and H. Logie Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin BMJ 329 7478 2004 1333
37. P. Adnet, P. Lestavel, and R. Krivosic-Horber Neuroleptic malignant syndrome Br J Anaesth 85 1 2000 129 135
38. P. Rosebush, and T. Stewart A prospective analysis of 24 episodes of neuroleptic malignant syndrome Am J Psychiatry 146 6 1989 717
39. J. Ananth, S. Parameswaran, and S. Gunatilake Neuroleptic malignant syndrome and atypical antipsychotic drugs J Clin Psychiatry 65 2004 464 470
40. M. Onofrj, and A. Thomas Acute akinesia in Parkinson disease Neurology 64 7 2005 1162 1169
41. Y.F. Wu, Y.S. Kan, and C.H. Yang Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease - a case report Gen Hosp Psychiatry 33 May (3) 2011 301.e7-301.e8
42. V.R. Velamoor Neuroleptic malignant syndrome. Recognition, prevention and management Drug Saf 19 1 1998 73